![Richard A. Canote](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard A. Canote
Plus aucun poste en cours
Profil
Richard A.
Canote worked as Vice President-Finance at Kémia, Inc. from 2004 to 2008.
He also worked as Chief Financial Officer at Response Biomedical Corp.
in 2012.
Canote served as Chief Financial Officer & Vice President at GeneOhm Sciences, Inc. and as Chief Financial Officer at Cytovia, Inc. Canote received his undergraduate degree from San Diego State University.
Anciens postes connus de Richard A. Canote
Sociétés | Poste | Fin |
---|---|---|
RESPONSE BIOMEDICAL CORP | Directeur Financier/CFO | 13/08/2012 |
Kémia, Inc.
![]() Kémia, Inc. Pharmaceuticals: MajorHealth Technology Kémia, Inc. discovered and developed novel small molecule therapeutics for inflammation, cancer, HIV, diabetes and bone diseases. The firm specialized in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development. The company was founded in 2002 and was headquartered in San Diego, CA. | Directeur Financier/CFO | 01/01/2008 |
Cytovia, Inc.
![]() Cytovia, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovia, Inc. provides biomedical research services. The firm discovers and develops therapeutics and products to assist physicians in curing cancer and certain degenerative diseases. The company was founded by Daniel Teper and is headquartered in San Diego, CA. | Directeur Financier/CFO | - |
GeneOhm Sciences, Inc.
![]() GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Directeur Financier/CFO | - |
Formation de Richard A. Canote
San Diego State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Kémia, Inc.
![]() Kémia, Inc. Pharmaceuticals: MajorHealth Technology Kémia, Inc. discovered and developed novel small molecule therapeutics for inflammation, cancer, HIV, diabetes and bone diseases. The firm specialized in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development. The company was founded in 2002 and was headquartered in San Diego, CA. | Health Technology |
GeneOhm Sciences, Inc.
![]() GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Cytovia, Inc.
![]() Cytovia, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovia, Inc. provides biomedical research services. The firm discovers and develops therapeutics and products to assist physicians in curing cancer and certain degenerative diseases. The company was founded by Daniel Teper and is headquartered in San Diego, CA. | Commercial Services |
Response Biomedical Corp.
![]() Response Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Response Biomedical Corp. engages in the research, development, commercialization, and distribution of diagnostic technologies. The firm serves the medical central-lab testing, point of care testing, and on-site environmental testing markets. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company was founded on August 20, 1980 and is headquartered in Vancouver, Canada. | Commercial Services |